The use of Alloxan and Streptozotocin in Experimental Diabetes Models;Deneysel Diyabet Modellerinde Alloksan ve Streptozotosin Kullanımı

Turkish Journal of Endocrinology and Metabolism

Volumn 16, Issue 2, 2012, Pages 34-40

  Kurçer, Zehra ^a   Karaoǧlu, Derya ^b  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

Alloxan; Experimental diabetes; Streptozotocin

Indexed keywords

ALLOXAN; STREPTOZOCIN;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; NONHUMAN; REVIEW; STREPTOZOCIN DIABETES;

EID: 84867515750     PISSN: 13012193     EISSN: 13089846     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. İrer SV, Alper G. Deneysel diyabet modelleri. Türk Klinik Biyokimya Derg 2004;2:127-36.
2. Bliss M. The Discovery of Insulin. 25. edition. Chicago: University of Chicago Press, 2007.
3. Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med 2005;22:359-70.
4. Szhudelsky T. The mechanism of alloksan and STZ action in beta cells of rat pancreas. Physiol Res 2001;50:536-46.
5. Dunn JS, Duffy E, Gilmour MK, Kirkpatrick J, McLetchie NG. Further observations on the effects of alloxan on the pancreatic islets. J Physiol 1944;103:233-43.
6. Rakieten N, Rakieten ML, Nadkarni MV. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 1963;29:91-8.
7. Lenzen S. The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia 2008;51:216-26.
8. Srinivasan K, Ramarao P. Animal models in type 2 diyabetes research: an overview. Indian J Med Res 2007;125: 451-72.
9. Bell RH, Hye RJ. Animal models of diabetes mellitus physiology and pathology. J Surg Res 1983;35:433-60.
10. Gorus FK, Malaisse WJ, Pipeleers DG. Selective uptake of alloxan by pancreatic B-cells. Biochem J 1982;208:513-5.
11. Lenzen S, Mirzaie-Petri M. Inhibition of glucokinase and hexokinase from pancreatic B-cells and liver by alloxan, alloxantin, dialuric acid, and tbutylhydroperoxide. Biomed Res 1991;12:297-307.
12. Lenzen S, Tiedge M, Panten U. Glucokinase in pancreatic B-cells and its inhibition by alloxan. Acta Endocrinol (Copenh) 1987;115:21-9.
13. Munday R. Dialuric acid autoxidation. Effects of transition metals on the reaction rate and on the generation of 'active oxygen' species. Biochem Pharmacol 1988;37:409-13.
14. Kim HR, Rho HW, Park BH, et al. Role of Ca2+ in alloxan-induced pancreatic beta-cell damage. Biochim Biophys Acta 1994;1227:87-91.
15. Golfman L, Dixon IM, Takeda N, et al. Cardiac sarcolemmal Na+-Ca2+ exchange and Na+-K+ ATPase activities and gene expression in alloxaninduced diabetes in rats. Mol Cell Biochem 1998;188:91-101.
16. Katsumata K, Katsumata K Jr, Katsumata Y. Protective effect of diltiazem hydrochloride on the occurrence of alloxan-or streptozotocin-induced diabetes in rats. Horm Metab Res 1992;24:508-10.
17. Sharma SB, Nasir A, Prabhu KM, Murthy PS. Antihyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus. J Ethnopharmacol 2006;104:367-73.
18. Kiersztan A, Winiarska K, Drozak J, et al. Differential effects of vanadium, tungsten and molybdenum on inhibition of glucose formation in renal tubules and hepatocytes of control and diabetic rabbits: beneficial action of melatonin and N-acetylcysteine. Mol Cell Biochem 2004;261:9-21.
19. Amalraj T, Ignacimuthu S. Evaluation of the hypoglycaemic effect of Memecylon umbellatum in normal and alloxan diabetic mice. J Ethnopharmacol 1998;62:247-50.
20. Zhang X, Liang W, Mao Y, et al. Hepatic glucokinase activity is the primary defect in alloxan-induced diabetes of mice. Biomed Pharmacother 2009;63:180-6.
21. Joharchi K, Jorjani M. The role of nitric oxide in diabetes-induced changes of morphine tolerance in rats. Eur J Pharmacol 2007;570:66-71.
22. Alarcon-Aguilar FJ, Roman-Ramos R, Flores-Saenz JL, Aguirre-Garcia F. Investigation on the hypoglycaemic effects of extracts of four Mexican medicinal plants in normal and alloxan-diabetic mice. Phytother Res 2002;16:383-6.
23. Miranda M, Muriach M, Almansa I, et al. CR-6 protects glutathione peroxidase activity in experimental diabetes. Free Radic Biol Med 2007;43:1494-8.
24. Sailaja Devi MM, Das UN. Effect of prostaglandins against alloxan-induced diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 2006;74:39-60.
25. Rajasekaran NS, Nithya M, Rose C, Chandra TS. The effect of finger millet feeding on the early responses during the process of wound healing in diabetic rats. Biochim Biophys Acta 2004;1689:90-201.
26. Liu W, Zhang X, Liu P, et al. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. Eur J Pharmacol 2010;638:150-5.
27. Vijayakumar MV, Bhat MK. Hypoglycemic effect of a novel dialysed fenugreek seeds extract is sustainable and is mediated, in part, by the activation of hepatic enzymes. Phytother Res 2008;22:500-5.
28. Sy GY, Cissé A, Nongonierma RB, et al. Hypoglycaemic and antidiabetic activity of acetonic extract of Vernonia colorata leaves in normoglycaemic and alloxan-induced diabetic rats. Ethnopharmacol 2005;98:171-5.
29. Howarth FC, Hassan Z, Qureshi MA. The chronic effects of neonatal alloxaninduced diabetes mellitus on ventricular myocyte shortening and cytosolic Ca 2+. Mol Cell Biochem 2011;347:71-7.
30. Soares de Alencar Mota C, Ribeiro C, de Araújo GG, et al. Exercise training in the aerobic/anaerobic metabolic transition prevents glucose intolerance in alloxan-treated rats. BMC Endocr Disord 2008;8:11.
31. Schnedl WJ, Ferber S, Johnson JH, Newgard CB. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 1994;43:1326-33.
32. Wang Z, Gleichmann H. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 1998;47:50-6.
33. West E, Simon OR, Morrison EY. Streptozotocin alters pancreatic beta-cell responsiveness to glucose within six hours of injection into rats. West Indian Med J 1996;45:60-2.
34. Bedoya FJ, Solano F, Lucas M. N-monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets. Experientia 1996;52:344-7.
35. Nukatsuka M, Yoshimura Y, Nishida M, Kawada J. Importance of the concentration of ATP in rat pancreatic beta cells in the mechanism of streptozotocin-induced cytotoxicity. J Endocrinol 1990;127:161-5.
36. Bolaffi JL, Nagamatsu S, Harris J, Grodsky GM. Protection by thymidine, an inhibitor of polyadenosine diphosphate ribosylation, of streptozotocin inhibition of insulin secretion. Endocrinology 1987;120:2117-22.
37. Yamamoto H, Uchigata Y, Okamoto H. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 1981;294:284-6.
38. Uchigata Y, Yamamoto H, Kawamura A, Okamoto H. Protection by superoxide dismutase, catalase, and poly(ADPribose) synthetase inhibitors against alloxan-and streptozotocin induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J Biol Chem 1982;257:6084-8.
39. Anderson T, Schein PS, McMenamin MG, Cooney DA. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide. J Clin Invest 1974;54:672-7.
40. Kröncke KD, Fehsel K, Sommer A, Rodri{dotless}guez ML, Kolb-Bachofen V. Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-Nnitroso-urea streptozotocin contributes to islet cell DNA damage. Biol Chem Hoppe Seyler 1995;376:179-85.
41. Nukatsuka M, Yoshimura Y, Nishida M, Kawada J. Allopurinol protects pancreatic beta cells from the cytotoxic effect of streptozotocin: in vitro study. J Pharmacobiodyn 1990;13:259-62.
42. Koh PO, Sung JH, Won CK, et al. Streptozotocin-induced diabetes decreases placenta growth factor (PlGF) levels in rat placenta. J Vet Med Sci 2007;69:877-80.
43. Wong TP, Debnam ES, Leung PS. Diabetes mellitus and expression of the enterocyte renin-angiotensin system: implications for control of glucose transport across the brush border membrane. Am J Physiol Cell Physiol 2009;297:601-10.
44. Kurcer Z, Parlakpinar H, Vardi N, et al. Protective effects of chronic melatonin treatment against renal ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Exp Clin Endocrinol Diabetes 2007;115:365-71.
45. Ishizaki E, Fukumoto M, Puro DG. Functional K(ATP) channels in the rat retinal microvasculature: topographical distribution, redox regulation, spermine modulation and diabetic alteration. J Physiol 2009;587:2233-53.
46. Liu SH, Chang YH, Chiang MT. Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats. J Agric Food Chem 2010; 58:5795-800.
47. De D, Chatterjee K, Ali KM, Bera TK, Ghosh D. Antidiabetic potentiality of the Aqueous-Methanolic Extract of Seed of Swietenia mahagoni (L.) Jacq. in Streptozotocin-induced Diabetic Male Albino Rat: A Correlative and Evidence-Based Approach with Antioxidative and Antihyperlipidemic Activities. Evid Based Complement Alternat Med 2011;2011:892807.
48. Shu XS, Lv JH, Tao J, et al. Antihyperglycemic effects of total flavonoids from Polygonatum odoratum in STZ and alloxan-induced diabetic rats. J Ethnopharmacol 2009;124:539-43.
49. Hogan S, Zhang L, Li J, et al. Antioxidant rich grape pomace extract suppresses postprandial hyperglycemia in diabetic mice by specifically inhibiting alpha-glucosidase. Nutr Metab (Lond) 2010;7:71.
50. Shen E, Li Y, Li Y, et al. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes 2009;58:2386-95.
51. Portha B, Levacher C, Pi{dotless}con L, Rosseli{dotless}n G. Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes 1974;23:889-95.
52. Daǧi{dotless}stanli{dotless} FK, Öztürk M. Yenidoǧan STZ Diyabet Modelinde Pankreatik Beta Hücre Rejenerasyonunu Kontrol Eden Genlerin Ekspresyonu. Cerrahpaşa Ti{dotless}p Dergisi 2007;38:127-138.
53. Sinzato YK, Damasceno DC, Laufer-Amorim R, et al. Plasma concentrations and placental immunostaining of interleukin-10 and tumor necrosis factor-α as predictors of alterations in the embryo-fetal organism and the placental development of diabetic rats. Braz J Med Biol Res 2011;44:206-11.
54. Masiello P, Broca C, Gross R, et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998;47:224-9.
55. Makom Ndifossap IG, Frigerio F, Casimir M, et al. Sclerocarya birrea (Anacardiaceae) stem-bark extract corrects glycaemia in diabetic rats and acts on beta-cells by enhancing glucose-stimulated insulin secretion. J Endocrinol 2010;205:79-86.
56. Kobayashi T, Taguchi K, Yasuhiro T, Matsumoto T, Kamata K. Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model. Hypertension 2004;44: 956-62.
57. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of highfat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005;52:313-20.
58. Zhang M, Lv XY, Li J, Xu ZG, Chen L. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008;2008:704045.
59. Leung JY, Kwok EW, Liu GY, Pang CC. Attenuated alpha-adrenoceptormediated arterial and venous constrictions in rat models of diabetes. Eur J Pharmacol 2010;642:128-33.
60. Huang BW, Chiang MT, Yao HT, Chiang W. The effect of high-fat and highfructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Diabetes Obes Metab 2004;6:120-6.
61. Oliveira DM, Freitas HS, Souza MF, et al. Yerba Maté (Ilex paraguariensis) aqueous extract decreases intestinal SGLT1 gene expression but does not affect other biochemical parameters in alloxan-diabetic Wistar rats. J Agric Food Chem 2008;56:10527-32.
62. Al-Salami H, Butt G, Tucker I, et al. Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats. Arch Drug Inf 2008;1:35-41.
63. Albayrak A, Uyanik MH, Odabasoglu F, et al. The Effects of Diabetes and/or polymicrobial sepsis on the status of antioxidant enzymes and proinflammatory cytokines on heart, liver, and lung of ovariectomized rats. J Surg Res 2011;169:67-75.
64. Musicki B, Kramer MF, Becker RE, Burnett AL. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetesassociated erectile dysfunction. Proc Natl Acad Sci U S A 2005;102:11870-5.
65. Raju J, Gupta D, Rao AR, Yadava PK, Baquer NZ. Trigonellafoenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 2001;224:45-51.
66. Daniel C, Schaub K, Amann K, Lawler J, Hugo C. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo. Diabetes 2007;56:2982-9.
67. Teng BS, Wang CD, Yang HJ, et al. A protein tyrosine phosphatase 1B activity inhibitor from the fruiting bodies of Ganoderma lucidum (Fr.) Karst and its hypoglycemic potency on streptozotocin-induced type 2 diabetic mice. J Agric Food Chem 2011;59:6492-500.
68. Mu J, Woods J, Zhou YP, et al. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes. Diabetes 2006;55:1695-704.